期刊文献+

血清甲状腺球蛋白、促甲状腺激素联合检测对行甲状腺全切术后未接受清甲治疗的分化型甲状腺癌患者复发的预测价值 被引量:3

Predictive value of serum thyroglobulin and TSH for recurrence of differentiated thyroid cancer after total thyroidectomy without remnant ablation
下载PDF
导出
摘要 目的探讨中低危分化型甲状腺癌(DTC)患者行甲状腺全切术(TT)后未接受清甲(RA)治疗时血清甲状腺球蛋白(Tg)水平和促甲状腺激素(TSH)水平对术后复发的预测价值。方法回顾性分析2014年1月至2019年7月间,在郑州人民医院接受TT的中低危分化型甲状腺癌患者112例,术后仅接受内分泌治疗未接受清甲治疗,无复发组(M0)105例、复发组(M1)7例。采用t检验、Mann⁃Whitney u秩和检验、χ^(2)检验和Fisher精确检验比较两组患者的基本临床病理特征,采用logistic回归分析筛选术后复发的独立影响因素,采用Spearman相关性分析探索Tg与TSH的关系,建立Tg、Tg/TSH与DTC复发的ROC曲线。结果两组间血清Tg、包膜侵犯、复发危险分层差异有统计学意义(P<0.05),性别、确诊年龄、肿瘤大小、淋巴结转移、TSH差异无统计学意义(P>0.05),其中Tg是DTC复发的独立影响因素。Tg与DTC复发关系的ROC曲线下面积为0.838,诊断界值为1.355μg/L,灵敏度85.7%、特异度82.9%。Spearman相关性分析结果显示Tg与TSH呈正相关,当Tg≥1.355μg/L时,M0组患者18例,M1组患者6例,两组患者中Tg/TSH差异有统计学意义(P<0.05),Tg/TSH与DTC患者复发关系的ROC曲线下面积为0.778,最佳界值为1.128,灵敏度66.67%、特异度100%。结论血清Tg、TSH联合检测可用于行TT后未接受RA的中低危DTC患者的术后随访,对疾病的复发有预测价值。 Objective To investigate the predictive value of serum thyroglobulin(Tg)and thyroid⁃stimu⁃lating hormone(TSH)for recurrence in intermediate and low⁃risk differentiated thyroid cancer(DTC)after total thyroidectomy(TT)without remnant ablation(RA).Methods This retrospective study engaged 121 patients with intermediate and low⁃risk differentiated thyroid cancer who received TT in Zhengzhou People's Hospital be⁃tween January 2014 and July 2019,with 105 patients in non⁃recurrence group(M0)and 7 patients in recurrence group(M1).The t test,Mann⁃Whitney U test,test,and Fisher's exact test were performed to evaluate the differ⁃ences in basic clinicopathological features among the 2 groups,and the logistic regression analysis was done to evaluate the independent influence on the recurrence of DTC patients.Spearman correlation analysis was done to ex⁃plore the relationship between Tg and TSH.The receiver operating characteristic(ROC)curve was analyzed to evaluate the predictive value of Tg and Tg/TSH for the DTC recurrence.Results Significant differences in the se⁃rum Tg,capsule invasion and recurrence risk were observed between the two groups(P<0.05),while no signifi⁃cant differences were seen in gender,age,tumor size,lymph node metastasis,and TSH between them(P>0.05).Tg was found to be an independent factor for the DTC recurrence.The areas under the ROC curve of Tg for predict⁃ing the DTC recurrence were 0.838.The cut⁃off value was 1.355μg/L,and the sensitivity and specificity were 85.7%and 82.9%,respectively.Spearman correlation analysis showed that Tg was positively correlated with TSH.When Tg was≥1.355μg/L,the number of patients reached 18 and 16 in the M0 group and the M1 group,respec⁃tively.There was a significant difference in Tg/TSH between the two groups(P<0.05).The areas under the ROC curve of Tg/TSH for predicting DTC recurrence was 0.778,the cut⁃off value was 1.128,and the sensitivity and specificity were 66.67%and 100.0%,respectively.Conclusion The combined detection of serum Tg and TSH can be used for postoperative follow⁃up of intermediate and low⁃risk DTC patients after TT without RA,and it is of value for predicting DTC recurrence.
作者 余江涛 王世杰 张高飞 段鑫鑫 霍青峰 张颂阳 郑守华 刘佩萸 YU Jiangtao;WANG Shijie;ZHANG Gaofei;DUAN Xinxin;HUO Qingfeng;ZHENG Shouhua;LIU Peiyu(Department of General Surgery,The Fifth Clinical Medical College(Zhengzhou People's Hospital),Henan University of Chinese Medicine,Zhengzhou 450000,China;不详)
出处 《实用医学杂志》 CAS 北大核心 2023年第9期1159-1163,共5页 The Journal of Practical Medicine
基金 河南省医学科技攻关项目(编号:SBGJ2018026) 河南省科技攻关项目(编号:222102310553)。
关键词 分化型甲状腺癌 肿瘤复发 甲状腺球蛋白 促甲状腺激素 differentiated thyroid cancer neoplasm recurrence thyroglobulin thyroid-stimulating hormone
  • 相关文献

参考文献4

二级参考文献32

  • 1王金果,林向阳,吴永根,周武.血清甲状腺自身抗体对甲状腺球蛋白测定的影响[J].中国实验诊断学,2007,11(5):662-663. 被引量:6
  • 2MASSART C, MAUGENDRE D. Importance of the detection method for thyroglohulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease[J']. Clin Chem,2002,48(1) :102-107.
  • 3PERSOON A C, LINKS T P, WILDE J, et al. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma[J]. Clin Chem, 2006,52(6) : 1196-1199.
  • 4OKOSIEME O E, EVANS C, MOSS L, et al. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: Relationship between epitope speeifieities and thyroglobulin reeovery[J]. Clin Chem, 2005,51(4) : 729-734.
  • 5FELDT-RASMUSSEN U, PROFILIS C, COLINET E, et al. Purification and assessment of stability and homogeneity of human thyroglobulin reference material (CRM457) [J]. Exp Clin Endocrinol, 1994,102:87.
  • 6DEMERS L M,SPENCER C A. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003, 13(1) : 57-67.
  • 7STANOJEVIC M,SAVIN S,CVEJI C D,et al. Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunoradiometric assay and the influence of thyroglobulin antibody[J]. J Immunoassay Immunochem. 2009,30(2):197-207.
  • 8ERALI M,BIGELOW R B,MEIKLE A W. ELISA for thyorglobulin in serum: recovery studies to evaluate autoantibody interference and reliability of thyroglobulin values[J]. Clin Chem, 1996,42 : 766-770.
  • 9TORTAJADA-GENARO L A, ROMERO M. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer[J]. Clin Chem Lab Med. 2008, 46 (10) : 1416-1422.
  • 10PONNUSAMY S, COLIN M. Thyroid autoantibody[J]. Endocrinol Metab Clin North Am, 2001,30(2) :315-337.

共引文献3308

同被引文献20

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部